Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 21;11(9):156.
doi: 10.1038/s41408-021-00538-9.

Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH-based algorithm distinguishes prognostic groups and outcomes

Zaid H Abdel-Rahman  1 , Michael G Heckman  2 , Theodora Anagnostou  3 , Launia J White  2 , Sara M Kloft-Nelson  4 , Ryan A Knudson  4 , Hassan B Alkhateeb  5 , Lisa Z Sproat  6 , Nandita Khera  6 , Hemant S Murthy  1 , Ernesto Ayala  1 , William J Hogan  5 , Vivek Roy  1 , Jess F Peterson  7 , Mohamed A Kharfan-Dabaja  1 , Rhett P Ketterling  7 , Mark R Litzow  5 , Linda B Baughn  7 , Mrinal Patnaik  5 , Patricia T Greipp #  7 , James M Foran #  8
Affiliations

Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH-based algorithm distinguishes prognostic groups and outcomes

Zaid H Abdel-Rahman et al. Blood Cancer J. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Outcomes of patients with Ph-like ALL in comparison to other groups.
A Overall survival of Ph-like, Ph-pos, and Ph-neg ALL. B Overall survival by cytogenetic subgroup. C Overall survival by MRD status. D Overall survival after allo-HCT.
See this image and copyright information in PMC

References

    1. Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, Miller CB, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med. 2009;360:470–80. doi: 10.1056/NEJMoa0808253. - DOI - PMC - PubMed
    1. Den Boer ML, van Slegtenhorst M, De Menezes RX, Cheok MH, Buijs-Gladdines JG, Peters ST, et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol. 2009;10:125–34. doi: 10.1016/S1470-2045(08)70339-5. - DOI - PMC - PubMed
    1. Jain N, Roberts KG, Jabbour E, Patel K, Eterovic AK, Chen K, et al. Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults. Blood. 2017;129:572–81. doi: 10.1182/blood-2016-07-726588. - DOI - PMC - PubMed
    1. Anagnostou T, Maloy MA, Patnaik MM, Arcila ME, Arteaga AG, Cho C, et al. Transplant characteristics and outcomes of Philadelphia (Ph)-like acute lymphoblastic leukemia (ALL) Biol Blood Marrow Transplant. 2020;26:S114–S115. doi: 10.1016/j.bbmt.2019.12.624. - DOI
    1. Abdel Rahman ZH, Heckman MG, Miller K, Alkhateeb H, Patnaik MS, Sproat LZ, et al. Impact of novel targeted therapies and cytogenetic risk groups on outcome after allogeneic transplantation for adult ALL. Transpl Cell Ther. 2020. - PubMed

Publication types